| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution |
Hirashima T, et al., Diabetes Res Clin Pract 1995 Feb;27(2):91-6. |
blood glucose amount |
male |
210.0 days
| 14 |
289.0 |
mg/dl |
8.55 |
32.0 |
oral glucose tolerance test |
|
0.0 |
oral dose |
120 |
min |
|
67277 |
729 |
| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 |
blood glucose amount |
male |
210.0 days
| 14 |
289.9 |
mg/dl |
8.7 |
32.55 |
oral glucose tolerance test |
|
0.0 |
oral glucose |
120 |
min |
|
68083 |
836 |
| OLETF |
serum triglyceride level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood triglyceride amount |
male |
246.0 days
| 23 |
218.77 |
mg/dl |
13.47 |
64.62 |
serum triglyceride analysis |
carotid artery |
|
|
|
|
Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
12359 |
248 |
| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution |
Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. |
blood glucose amount |
male |
210.0 days
| 14 |
149.2 |
mg/dl |
3.0 |
11.22 |
oral glucose tolerance test |
|
|
glucose challenge |
|
min |
|
12776 |
312 |
| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 |
blood glucose amount |
male |
210.0 days
| 14 |
149.2 |
mg/dl |
3.0 |
11.22 |
oral glucose tolerance test |
|
0.0 |
oral glucose |
|
min |
|
68071 |
836 |
| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 |
blood glucose amount |
male |
210.0 days
| 14 |
352.8 |
mg/dl |
8.6 |
32.18 |
oral glucose tolerance test |
|
0.0 |
oral glucose |
60 |
min |
|
68077 |
836 |
| OLETF |
serum total cholesterol level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood cholesterol amount |
male |
246.0 days
| 23 |
90.1 |
mg/dl |
2.2 |
10.56 |
serum total cholesterol measurement test |
carotid artery |
|
|
|
|
Cholesterol E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
12352 |
248 |
| OLETF |
body weight |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
body mass |
male |
246.0 days
| 23 |
641.0 |
g |
6.92 |
33.21 |
body weighing method |
|
|
|
|
|
|
12363 |
248 |
| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution (for 0.5 hours) |
Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. |
blood glucose amount |
male |
210.0 days
| 14 |
344.3 |
mg/dl |
8.5 |
31.8 |
oral glucose tolerance test |
|
0.0 |
glucose challenge |
30 |
min |
|
12777 |
312 |
| OLETF |
serum leptin level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood leptin amount |
male |
246.0 days
| 23 |
10.87 |
ng/ml |
0.57 |
2.71 |
enzyme linked immunosorbent assay |
carotid artery |
0 |
|
|
|
immunoreactive leptin kit; Morinaga Institute of Biological Science, Yokohama, Japan |
65739 |
248 |
| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 |
blood glucose amount |
male |
210.0 days
| 14 |
344.3 |
mg/dl |
8.5 |
31.8 |
oral glucose tolerance test |
|
0.0 |
oral glucose |
30 |
min |
|
68074 |
836 |
| OLETF |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 |
blood glucose amount |
male |
210.0 days
| 14 |
402.4 |
mg/dl |
19.0 |
71.09 |
oral glucose tolerance test |
|
0.0 |
oral glucose |
90 |
min |
|
68080 |
836 |